the first angiographic study at the end of the infusion revealed a patent infarct-related artery ( thrombolysis in myocardial infarction trial [ timi ] grade 2 or 3 ) in 69.4 % of 121 patients given rt-pa versus 65.8 % of 117 patients given urokinase ( p = ns ) .
C0027051
myocardial infarction
C0042071
urokinase